Form 4: Adaptive Biotechnologies SVP Taylor Reports Stock Transactions

Stacy L Taylor, SVP and General Counsel of Adaptive Biotechnologies, reports acquisition and disposal of company stock and stock options to cover tax obligations.

Summary

• Stacy L Taylor, SVP and General Counsel of Adaptive Biotechnologies, filed a Form 4 detailing changes in beneficial ownership.
• On March 4, 2024, Taylor acquired 39,990 shares of common stock.
• On March 5, 2024, Taylor sold 6,772 shares at $3.43 and 6,609 shares at $3.44 to cover tax withholding obligations related to vesting RSUs.
• Following these transactions, Taylor beneficially owns 166,287 shares of common stock.
• Taylor also acquired 60,010 stock options with an exercise price of $3.99 on March 4, 2024, vesting in installments starting March 4, 2025, and expiring on March 4, 2034.

Sentiment

Score: 5

Explanation: Neutral sentiment. The transactions are routine and primarily related to tax obligations. The acquisition of options is a slightly positive signal, but the stock sales offset this.

Positives

• The acquisition of stock options could be seen as a positive sign of confidence in the company's future.

Negatives

• The sale of shares, although for tax obligations, could be perceived negatively by some investors.

Risks

• The stock sales to cover tax obligations could create temporary selling pressure on the stock.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Similar to other biotechnology companies, Adaptive Biotechnologies uses stock options and RSUs as part of its compensation packages to align employee incentives with shareholder value.
• The 'sell to cover' practice for tax obligations is a common method used by companies to manage the tax implications of equity compensation for their employees.

Stakeholder Impact

• The stock sales could have a minor, temporary impact on shareholders due to potential selling pressure.

Key Dates